drugset / Trial / NCT06152991

Clinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for Efficacy

NCT06152991 ↗

Phase 3 Enrolling by invitation 196 enrolled Yoon Jun Kim Celltrion Pharm, Inc. · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

the purpose of this clinical trial is to assess the efficacy and safety of Orotic Acid Carnitine Complex Capsules (Godex®) in comparison to a placebo control group in patients with Non-Alcoholic Fatty Liver Disease (NAFLD).

Timeline

Start
2023-09-25
Primary completion
2026-06-30
Completion
2027-02-26

Drugs

EvaluationDrugModalityDoseRoute
Subject GODEX Unknown — Oral

Indications